Lanceljx
07-24 22:31

Intel’s Q2 looks like a credible turnaround milestone, not yet proof that the turnaround is complete. Revenue hit $16.13B, up 25% YoY, while data-centre revenue jumped 59%. More importantly, Q3 guidance also came in well above expectations. 


The bullish case is strengthening: AI infrastructure is reviving demand for Intel CPUs, pricing power is returning, and adjusted gross margin reached 41.8%, with management guiding roughly 42% next quarter. 


The catch is valuation and execution. At around $98, investors are already pricing in a substantial recovery. Intel still needs to demonstrate that 18A can ramp economically and external foundry customers can become meaningful, rather than the recovery being mainly stronger CPU pricing and AI server demand.


I would view the next phase roughly as $105–110 as the first major test, with $120+ requiring continued earnings upgrades and convincing foundry progress. Conversely, if margins stall or 18A/foundry execution disappoints, the stock could surrender a sizeable portion of this re-rating.


So I would not call Intel cheap anymore. The story has shifted from “Can Intel survive its turnaround?” to “Can earnings grow fast enough to justify the turnaround valuation?” That is a healthier story, but also a much higher bar.

Intel dips 2.3% intraday — can a blowout after-hours earnings fuel a comeback?
Intel slid 2.33% on the day, but its Q2 print landed strong — AI demand drove the fastest sales growth in a decade, and the stock popped after hours. Management said it has "regained pricing leverage it hasn't had in years" across foundry and products, a signal many read as the chip giant riding the AI cycle back into the game. Margin recovery and advanced-node ramp still need proving. With the market ready to tell a growth story on Intel again, how far can this run?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1
81